AKT1 and acute lymphoblastic leukemia: Although PI3Kδ can activate the AKT pathway, which restrains glucocorticoid potency in some T-ALL [11], we found that AKT had no effect on glucocorticoid sensitivity in the B-ALL specimens tested [10].